Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al.

Agca R, Heslinga SC, Rollefstad S, Heslinga S, Södergren A, Semb AG, Kitas GD, Sattar N, Nurmohamed MT; EULAR task force “EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update”.

Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215748. doi: 10.1136/annrheumdis-2019-215748. [Epub ahead of print] No abstract available.

PMID:
31413003
2.

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis.

Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Kamp O, van Halm VP, de Bruin-Bon H, Peters MJ, Nurmohamed MT.

Biologics. 2018 Nov 8;12:143-149. doi: 10.2147/BTT.S176806. eCollection 2018.

3.

Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study.

van Bentum RE, Heslinga SC, Nurmohamed MT, Gerards AH, Griep EN, Koehorst CBJM, Kok MR, Schilder AM, Verhoef M, van der Horst-Bruinsma IE.

J Rheumatol. 2019 Feb;46(2):153-159. doi: 10.3899/jrheum.180312. Epub 2018 Nov 1.

4.

Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance.

Biesbroek PS, Heslinga SC, van de Ven PM, Peters MJL, Amier RP, Konings TC, Maroules CD, Ayers C, Joshi PH, van der Horst-Bruinsma IE, van Halm VP, van Rossum AC, Nurmohamed MT, Nijveldt R.

Clin Rheumatol. 2018 Aug;37(8):2151-2159. doi: 10.1007/s10067-018-4135-x. Epub 2018 May 12.

PMID:
29754182
5.

The Relationship Between Cardiac Conduction Times, Cardiovascular Risk Factors, and Inflammation in Patients with Early Arthritis.

Turk SA, Heslinga SC, Dekker J, Britsemmer L, van der Lugt V, Lems WF, van Schaardenburg D, Nurmohamed MT.

J Rheumatol. 2017 May;44(5):580-586. doi: 10.3899/jrheum.161184. Epub 2017 Apr 1.

PMID:
28365582
6.

Insights into cardiac involvement in ankylosing spondylitis from cardiovascular magnetic resonance.

Biesbroek PS, Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Hofman MBM, van de Ven PM, Kamp O, van Halm VP, Peters MJL, Smulders YM, van Rossum AC, Nurmohamed MT, Nijveldt R.

Heart. 2017 May;103(10):745-752. doi: 10.1136/heartjnl-2016-310667. Epub 2016 Nov 16.

PMID:
27852696
7.

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT.

Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3. Review.

PMID:
27697765
8.

Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders.

Agca R, Heslinga SC, van Halm VP, Nurmohamed MT.

Heart. 2016 May 15;102(10):790-5. doi: 10.1136/heartjnl-2015-307838. Epub 2016 Feb 17. Review.

PMID:
26888573
9.

Reduction of Inflammation Drives Lipid Changes in Ankylosing Spondylitis.

Heslinga SC, Peters MJ, Ter Wee MM, van der Horst-Bruinsma IE, van Sijl AM, Smulders YM, Nurmohamed MT.

J Rheumatol. 2015 Oct;42(10):1842-5. doi: 10.3899/jrheum.150193. Epub 2015 Sep 1.

PMID:
26329334
10.

Study on the protective effect of the KIR3DL1 gene in ankylosing spondylitis.

Vendelbosch S, Heslinga SC, John M, van Leeuwen K, Geissler J, de Boer M, Tanck MW, van den Berg TK, Crusius JB, van der Horst-Bruinsma IE, Kuijpers TW.

Arthritis Rheumatol. 2015 Nov;67(11):2957-65. doi: 10.1002/art.39288.

11.

Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation.

Heslinga SC, Van den Oever IA, Van Sijl AM, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT.

BMC Musculoskelet Disord. 2015 Apr 9;16:80. doi: 10.1186/s12891-015-0532-3.

12.

Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review.

Heslinga SC, Van Sijl AM, De Boer K, Van Halm VP, Nurmohamed MT.

Curr Med Chem. 2015;22(16):1892-902. Review.

PMID:
25666788
13.

Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis.

Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT.

Semin Arthritis Rheum. 2014 Aug;44(1):14-9. doi: 10.1016/j.semarthrit.2014.02.004. Epub 2014 Feb 14. Review.

PMID:
24655534

Supplemental Content

Loading ...
Support Center